Published in Hypertension on July 01, 1998
Developmental programming of aortic and renal structure in offspring of rats fed fat-rich diets in pregnancy. J Physiol (2005) 1.32
Biomechanics of the cardiovascular system: the aorta as an illustratory example. J R Soc Interface (2006) 1.08
Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension. Br J Pharmacol (2010) 0.92
Should there be sex-specific criteria for the diagnosis and treatment of heart failure? J Cardiovasc Transl Res (2013) 0.87
Mechanisms of arterial remodeling: lessons from genetic diseases. Front Genet (2012) 0.85
Stiffness of the large arteries in individuals with and without Down syndrome. Vasc Health Risk Manag (2011) 0.80
Influence of hypertension and smoking as the single vascular risk factors on the intima-media thickness. Eur J Epidemiol (2001) 0.79
Anti-platelet therapy with clopidogrel prevents endothelial dysfunction and vascular remodeling in aortas from hypertensive rats. PLoS One (2014) 0.78
Hypertension control at hospital discharge after acute coronary event: influence on cardiovascular prognosis--the PREVENIR study. Heart (2002) 0.77
Hypertension research program at ochsner: a program in translational research. Ochsner J (2002) 0.76
Wall shear stress in hypertensive patients is associated with carotid vascular deformation assessed by speckle tracking strain imaging. Clin Hypertens (2014) 0.76
Vascular dysfunctions in the isolated aorta of double-transgenic hypertensive mice developing aortic aneurysm. Pflugers Arch (2014) 0.76
Mechanical stress and human aortic smooth muscle cell proliferation. Exp Clin Cardiol (2001) 0.75
Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension (2001) 11.18
Human blood pressure determination by sphygmomanometry. Circulation (1993) 7.88
Impact of aortic stiffness on survival in end-stage renal disease. Circulation (1999) 7.17
Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension (2001) 4.70
Diabetes, hypertension, and cardiovascular disease: an update. Hypertension (2001) 4.62
Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension (1999) 4.56
Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant (2000) 3.99
Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke (2001) 3.99
The paradox of beta-adrenergic blockade in hypertension. Circulation (1968) 3.78
Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation (2001) 3.35
Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension (1998) 2.28
Mercury sphygmomanometers should not be abandoned: An advisory statement from the Council for High Blood Pressure Research, American Heart Association. Hypertension (2001) 2.20
European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens (2010) 2.06
Review of the overall experience of captopril in hypertension. Arch Intern Med (1984) 1.99
Pulse pressure and aortic pulse wave are markers of cardiovascular risk in hypertensive populations. Am J Hypertens (2001) 1.89
Immediate hemodynamic effects of beta-adrenergic blockade with propranolol in normotensive and hypertensive man. Circulation (1968) 1.82
Similarities of genetic (spontaneous) hypertension. Man and rat. Circ Res (1981) 1.75
One-year longitudinal study of a no-smoking policy in a medical institution. Chest (1990) 1.75
Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med (1980) 1.73
Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension (2001) 1.70
Comparative effects of aging in men and women on the properties of the arterial tree. J Am Coll Cardiol (2001) 1.65
Evaluation of the initial care of hypertensive patients. JAMA (1971) 1.64
TGF-beta1 polymorphisms and arterial stiffness; the Rotterdam Study. J Hum Hypertens (2007) 1.59
Hyperdynamic beta-adrenergic circulatory state. Arch Intern Med (1966) 1.57
Influence of body height on pulsatile arterial hemodynamic data. J Am Coll Cardiol (1998) 1.56
Wave reflections and cardiac hypertrophy in chronic uremia. Influence of body size. Hypertension (1993) 1.56
Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int (2001) 1.54
Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease. Kidney Int (2006) 1.53
Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats. J Lab Clin Med (1971) 1.51
Effect of methyldopa, clonidine, and hydralazine on cardiac mass and haemodynamics in Wistar Kyoto and spontaneously hypertensive rats: an historical account and some follow-up. Cardiovasc Res (2000) 1.49
Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity. Arch Intern Med (1981) 1.48
Association between high heart rate and high arterial rigidity in normotensive and hypertensive subjects. J Hypertens (1997) 1.41
The evolution of antihypertensive therapy: an overview of four decades of experience. J Am Coll Cardiol (1989) 1.39
Hypertension means high blood pressure. Hypertension (1994) 1.39
Reference sample microsphere method: cardiac output and blood flows in conscious rat. Am J Physiol (1980) 1.37
Arterial pressure responses to discontinuing antihypertensive drugs. Circulation (1968) 1.37
Essential hypertension in the elderly: haemodynamics, intravascular volume, plasma renin activity, and circulating catecholamine levels. Lancet (1983) 1.36
Hypertension and sudden death. Increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med (1984) 1.31
Pulse pressure: Is this a clinically useful risk factor? Hypertension (1999) 1.27
Pulsatile diameter and elastic modulus of the aortic arch in essential hypertension: a noninvasive study. J Am Coll Cardiol (1989) 1.26
Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int (1997) 1.24
Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment. Nephrol Dial Transplant (2001) 1.19
Task Force II: blood pressure measurement and cardiovascular outcome. Blood Press Monit (2001) 1.18
Long-term thiazide therapy in essential hypertension. Evidence for persistent alteration in plasma volume and renin activity. Circulation (1970) 1.18
Tilt test for investigating a neural component in hypertension. Its correlation with clinical characteristics. Circulation (1967) 1.17
Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med (1983) 1.16
Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output. Circulation (1982) 1.16
Cardiac function and morphology with aging in the spontaneously hypertensive rat. Am J Physiol (1979) 1.14
Stiffness of carotid artery wall material and blood pressure in humans: application to antihypertensive therapy and stroke prevention. Stroke (2000) 1.14
Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation (1996) 1.14
Hyperdynamic beta-adrenergic circulatory state. Increased beta-receptor responsiveness. Arch Intern Med (1969) 1.14
Arterial and venous compliance in sustained essential hypertension. Hypertension (1987) 1.14
Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy? Am J Cardiol (1979) 1.13
Racial differences in pressure, volume and renin interrelationships in essential hypertension. Hypertension (1981) 1.13
Plasma volume and chronic hypertension. Relationship to arterial pressure levels in different hypertensive diseases. Arch Intern Med (1970) 1.12
Arterial distensibility and left ventricular hypertrophy in patients with sustained essential hypertension. Am Heart J (1991) 1.12
Pathophysiology of anaemia: focus on the heart and blood vessels. Nephrol Dial Transplant (2000) 1.12
Left ventricular hypertrophy and sudden death. J Am Coll Cardiol (1998) 1.11
Regional blood flows measured in conscious rats by combined Fick and microsphere methods. Am J Physiol (1978) 1.10
A renewed call to mentor. Hypertension (2000) 1.08
Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol (1998) 1.07
Editorial: Use and abuse of diuretics. Am Heart J (1975) 1.07
Pumping ability of the hypertrophying left ventricle of the spontaneously hypertensive rat. Circ Res (1976) 1.06
Clinical-physiological correlations in the development of hypertensive heart disease. Circulation (1971) 1.06
Pathophysiologic assessment of hypertensive heart disease with echocardiography. Am J Cardiol (1977) 1.06
Self-measurement of blood pressure in clinical trials and therapeutic applications. Blood Press Monit (2000) 1.04
Plasma volume in men with essential hypertension. N Engl J Med (1968) 1.02
Immediate hemodynamic effects of a dopamine-receptor agonist (fenoldopam) in patients with essential hypertension. Circulation (1984) 1.01
Pathophysiology of cardiovascular disease in hemodialysis patients. Kidney Int Suppl (2000) 1.01
Carotid arterial haemodynamics after mild degrees of lower-body negative pressure in man. Clin Sci (Lond) (1992) 1.01
Pathophysiologic significance of "stress" or relative polycythemia in essential hypertension. Am J Cardiol (1976) 1.00
Angiotensin type 1 receptor antagonism and ACE inhibition produce similar renoprotection in N(omega)-nitro-L>-arginine methyl ester/spontaneously hypertensive rats. Hypertension (2001) 1.00
Plasma homocysteine, aortic stiffness, and renal function in hypertensive patients. Hypertension (1999) 1.00
Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension. Circulation (1988) 1.00
Angiotensin II increases left ventricular mass without affecting myosin isoform mRNAs. Hypertension (1996) 0.99
Greater renal vascular involvement in the black patient with essential hypertension. A comparison of systemic and renal hemodynamics in black and white patients. Miner Electrolyte Metab (1984) 0.99
Physiological comparison of labile and essential hypertension. Circ Res (1970) 0.99
Beta adrenergic blockade in the circulatory regulation of hyperkinetic states. Am J Cardiol (1971) 0.98
Recommendations for blood pressure determination by sphygmomanometry. Ann Intern Med (1988) 0.98
Changes in arterial structure and function under trandolapril-verapamil combination in hypertension. Stroke (1999) 0.98
Racial differences in cardiac adaptation to essential hypertension determined by echocardiographic indexes. J Am Coll Cardiol (1983) 0.97
Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension. Am J Cardiol (1984) 0.97
Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension. Am J Hypertens (1997) 0.97
Renal filtration fraction, effective vascular compliance, and partition of fluid volumes in sustained essential hypertension. Kidney Int (1981) 0.97
Re-examination of the hemodynamics of hypertension. Am J Med Sci (1969) 0.96
Effects of weight reduction on arterial pressure. J Chronic Dis (1982) 0.95
Total vascular pressure-volume relationship in the conscious rat. Am J Physiol (1980) 0.95
Ticrynafen: a novel uricosuric antihypertensive natriuretic agent. Arch Intern Med (1978) 0.95
Limited echocardiography for hypertensive left ventricular hypertrophy. Hypertension (1997) 0.95
Electrocardiographic changes reflecting left atrial abnormality in hypertension. Circulation (1966) 0.94
Renal haemodynamic studies in obesity hypertension. J Hypertens (1987) 0.94
Arterial dynamics, cardiac hypertrophy, and antihypertensive treatment. Circulation (1987) 0.94
Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in essential hypertension. Clin Exp Pharmacol Physiol (2001) 0.94
Left atrial abnormality and ventricular preejection period in hypertension. Dis Chest (1969) 0.94
Cardiac output and distribution of blood volume in central and peripheral circulations in hypertensive and normotensive man. Br Heart J (1969) 0.94